Abstract
Heterozygous germline mutations in PTEN are responsible for most cases of Cowden Syndrome, a rare familial trait characterized by hamartomas and by predisposition to cancer of the breast and thyroid. The variable and often subtle clinical findings that characterize Cowden Syndrome are frequently unrecognized, raising the possibility that germline PTEN mutations may confer susceptibility to breast cancer in women who have not been diagnosed with this syndrome. To determine whether such mutations contribute to genetic predisposition to breast cancer within the general population, we analysed a cohort of women with early-onset breast cancer (<age 40), a subset of the population at increased risk for genetic susceptibility. Lymphoblast cell lines were analysed using either direct nucleotide sequencing (28 cases), denaturing gradient gel electrophoresis (DGGE) (34 cases) or a yeast-based truncation assay (110 cases). No definitive, truncating mutations were observed in 172 patients. Missense changes were noted in the germline of 2/60 patients analysed by direct nucleotide sequencing or DGGE, including a non-conservative amino acid substitution within the phosphatase domain, but neither showed loss of the wild-type allele in the corresponding breast tumor specimen. We conclude that germline mutations in PTEN are an uncommon cause of genetic predisposition to breast cancer within the general population.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
FitzGerald, M., Marsh, D., Wahrer, D. et al. Germline mutations in PTEN are an infrequent cause of genetic predisposition to breast cancer. Oncogene 17, 727–731 (1998). https://doi.org/10.1038/sj.onc.1201984
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1201984
Keywords
This article is cited by
-
Deubiquitylase OTUD3 regulates PTEN stability and suppresses tumorigenesis
Nature Cell Biology (2015)
-
Clinical and molecular characterization of the BRCA2 p.Asn3124Ile variant reveals substantial evidence for pathogenic significance
Breast Cancer Research and Treatment (2014)
-
Breast cancer genome-wide association studies: there is strength in numbers
Oncogene (2012)
-
Expression of the BRCA1 complex member BRE predicts disease free survival in breast cancer
Breast Cancer Research and Treatment (2012)
-
Cowden Syndrome: A Critical Review of the Clinical Literature
Journal of Genetic Counseling (2009)